Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Scotland eyes stenting to treat lower-limb PAD (peripheral arterial disease):

This article was originally published in Clinica

Executive Summary

Scotland has decided not to conduct a health technology assessment on the use of stents in the treatment of peripheral arterial disease (PAD) of the lower limbs, but calls for research to be conducted in this area. NHS Quality Improvement Scotland found that current evidence would add little or no value to the study Endovascular stents for intermittent claudication, published by the Cochrane Review in 2002. Scotland's HTA body believes that "high quality randomised controlled trials are imperative" to determine whether percutaneous transluminal angioplasty (PTA) combined with stenting is clinically and cost effective in the treatment of PAD. Lower-limb PAD affects some 3% of people aged under 60 years and 20% of under-75s. The main symptom of PAD is intermittent claudication, which includes activity-induced pain and weakness. Treatment options include bypass surgery, endarterectomy and PTA (with or without a stent).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT062724

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel